[Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis].

Funke, Manuela; Geiser, Thomas (2016). [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]. Therapeutische Umschau, 73(1), pp. 25-29. Huber 10.1024/0040-5930/a000751

Full text not available from this repository. (Request a copy)

Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Funke, Manuela and Geiser, Thomas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0040-5930

Publisher:

Huber

Language:

German

Submitter:

Rahel Holderegger

Date Deposited:

22 Mar 2017 15:28

Last Modified:

30 Sep 2017 16:00

Publisher DOI:

10.1024/0040-5930/a000751

PubMed ID:

26884217

URI:

https://boris.unibe.ch/id/eprint/93081

Actions (login required)

Edit item Edit item
Provide Feedback